title: Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease.
authors.affiliation: University Department of Clinical Neurosciences, Royal Free and University College Medical School, UCL, Queen Square, London, United Kingdom. schapira@rfc.ucl.ac.uk
authors.forename: Anthony H V
authors.initials: AH
authors.lastname: Schapira
authors.forename: C Warren
authors.initials: CW
authors.lastname: Olanow
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D018696:Neuroprotective Agents